Skip to content

CBUYS

Active
Private limited company·Activiteiten van tandartspraktijken· 4 yrs active
Goordijk 15 ·2360 Oud-Turnhout, Belgium
KBO/BCE: BE 0773.760.585
Watch Print / PDF
Age4 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of CBUYS is 0.2% (very low). The 2025 annual accounts show equity of €3k and a net result of €76k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 14% of 2217 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 5 annual accounts.

Signals

2 signals · with evidence
Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 2217 sector peers (2025).
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-03-2026, 134 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 5 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 19-03-2026 134 d early 2026-00058214
31-12-2024 31-07-2025 09-07-2025 22 d early 2025-00251166
31-12-2023 31-07-2024 19-06-2024 42 d early 2024-00146333
31-12-2022 31-07-2023 24-07-2023 7 d early 2023-00263243
31-12-2021 31-07-2022 02-05-2022 90 d early 2022-20018616

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€76k+25.0%
Working capital€-12k-3.7%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 19-03-2026 with the NBB · fiscal year 2025 · micro
€0€25k€50k€75k€100kOperating result 2021: €39k€39kNet result 2021: €29k€29kOperating result 2022: €59k€59kNet result 2022: €46k€46kOperating result 2023: €35k€35kNet result 2023: €27k€27kOperating result 2024: €78k€78kNet result 2024: €61k€61kOperating result 2025: €96k€96kNet result 2025: €76k€76k20212022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
volatile Too volatile to project: the yearly deviation from the trend is ~45% of the level (threshold 35%). We therefore deliberately show no projection line.
€0€20k€40k€60k€80k2021: €29k2022: €75k2023: €38k2024: €3k2025: €3k20212022202320242025
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 2.9% 58.2%
better than 14% of 2217 sector peers
Net result €76k €60k
better than 58% of 2215 sector peers
Equity €3k €74k
better than 12% of 2217 sector peers
Gross operating margin €112k €95k
better than 56% of 2217 sector peers
Staff costs €2k €22k
higher than 20% of 361 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P14
2021: P53 · n=18482022: P38 · n=36842023: P29 · n=53462024: P7 · n=65822025: P14 · n=22172021 2025
Weakening position over 2021-2025 · n=1848-6582
Net result P58
2021: P39 · n=18482022: P55 · n=36822023: P40 · n=53452024: P60 · n=65762025: P58 · n=22152021 2025
Improving position over 2021-2025 · n=1848-6576
Equity P12
2021: P31 · n=18482022: P58 · n=36842023: P35 · n=53482024: P7 · n=65822025: P12 · n=22172021 2025
Weakening position over 2021-2025 · n=1848-6582
Gross operating margin P56
2021: P30 · n=18492022: P51 · n=36802023: P40 · n=53422024: P57 · n=65842025: P56 · n=22172021 2025
Improving position over 2021-2025 · n=1849-6584
Describes the position versus peers, not a forecast.
EBITDA
€110k
+20.5% 21-25
Net profit
€76k
+25.0% 21-25
Cash flow
€89k
+21.3% 21-25
Total assets
€104k
+1.8% 21-25
Equity
€3k
0.0% 21-25
Working capital
€-12k
-3.7% 21-25
Staff costs
€2k
-10.5% 21-25
Income taxes
€20k
+22.5% 21-25
Dividends
€76k
-20.7% 21-25
Debt
€101k
+1.8% 21-25
Debt ≤ 1y
€94k
+16.0% 21-25
Debt > 1y
€7k
-62.6% 21-25
Current ratio
0.87
+1.7% 21-25
Quick ratio
0.87
+1.7% 21-25
Solvency
2.9%
-1.7% 21-25
Debt / equity
33.72
+1.8% 21-25
ROE
2536.5%
+25.0% 21-25
ROA
73.1%
+22.9% 21-25
Interest coverage
143.77
+69.1% 21-25
Figures by fiscal year
Fiscal year2025
Depositmicro
Revenue-
EBITDA€110k
Net profit€76k
Cash flow€89k
Staff costs€2k
Income taxes€20k
Dividends€76k
Total assets€104k
Equity€3k
Debt€101k
of which ≤ 1y€94k
of which > 1y€7k
Working capital€-12k
Employees (FTE)-
Ratios (computed)
2025
Current ratio0.87
Quick ratio0.87
Working capital ratio-11.5%
Solvency2.9%
Debt / equity33.72
Long-term debt ratio2.24
Interest coverage143.77
Gross margin-
Net margin-
ROA73.1%
ROE2536.5%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€104k
Fixed assets 21/28€22k
Tangible fixed assets 22/27€22k
Current assets 29/58€83k
Amounts receivable within one year 40/41€18k
Investments 50/53€0
Cash & bank 54/58€61k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€104k
Equity 10/15€3k
Contributions / capital 10/11€3k
Accumulated profits (losses) 14€0
Amounts payable 17/49€101k
Amounts payable after one year 17€7k
Amounts payable within one year 42/48€94k
Income statement
Gross operating margin 9900€112k
Operating result 9901€96k
Financial income 75€338
Financial charges 65€763
Result before taxes 9903€96k
Income taxes 67/77€20k
Net result for the period 9904€76k
Result to be appropriated 9905€76k
This table shows the latest fiscal year. 4 prior years, with figures and ratios, belong to a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
53 / 100 Fair
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Goordijk 152360 Oud-Turnhout

Establishment units

1 location
CBUYS
Goordijk 15, 2360 Oud-TurnhoutVervaardiging van medische en tandheelkundige instrumenten en benodigdheden
since 20212.321.926.909
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area4,023 m²
Buildings1
Building footprint279 m²
Volume (LiDAR)1,663 m³
Tallest building9.5 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
13482F1176/00H003 Flanders 4,023 m² 1 · 279 m² 9.5 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

No structured acts for this company yet

That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.

Analysis

Snowflake analysis

financial profile on 5 axes
Health53Profitability100Solvency10Growth58Stability94
63 / 100

Strong profile, led by profitability.

All 5 axes are computed from data Checked has read.

Health 53
Profitability 100
Solvency 10
Growth 58
Stability 94

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Tandartspraktijken86230Activiteiten van tandartspraktijken86230Overige menselijke gezondheidszorg, n.e.g.86909Activiteiten op het gebied van voeding86995
Primary activity highlighted.
Names & trade names
Legal nameNL CBUYS
Registered office
Goordijk 15
2360 Oud-Turnhout, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.